Biocon Biologics unveils Yesintek biosimilar to Stelara in US Ruchika Sharma25 Feb 2025 12:31 PM ISTYESINTEK will be available in all the same formulations currently provided by Stelara.
Biocon, Equillium announce positive data from Phase 2 Study evaluating Itolizumab for Ulcerative Colitis Ruchika Sharma7 Feb 2025 11:30 AM ISTBengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global biopharmaceutical company, have...
Genetic Study Links Anterior Uveitis to Autoimmune Diseases Dr. Kamal Kant Kohli31 Jan 2025 8:30 PM ISTAn international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with inflammation of...
Wearable devices can detect and predict inflammatory bowel disease flare-ups, Mount Sinai study finds Dr. Kamal Kant Kohli17 Jan 2025 9:45 PM ISTWearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease...
CDSCO panel approves Sanofi's proposal to increase number of subjects from 25 to 40 in india to study SAR443122 Dr. Divya Colin5 Jan 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
JnJ seeks USFDA approval for Simponi to treat pediatric ulcerative colitis Ruchika Sharma19 Dec 2024 12:42 PM ISTDeveloped by Johnson & Johnson, SIMPONI is an anti-TNF biologic medicine that targets and blocks a protein called TNF-alpha.
USFDA approves Biocon Biologics Yesintek for Crohn's disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis Ruchika Sharma2 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the U.S. Food ...
JnJ seeks USFDA approval for subcutaneous induction regimen of Tremfya in ulcerative colitis Ruchika Sharma29 Nov 2024 11:30 AM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis Dr. Kamal Kant Kohli26 Nov 2024 8:15 PM ISTThe American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe...
Ulcerative colitis causally related to male infertility, claims research Dr. Shravani Dali17 Nov 2024 8:45 PM ISTUlcerative colitis causally related to male infertility, claims research published in the PLOS ONE.A study was done to explore the causal...
Researchers develop probiotic to ameliorate ulcerative colitis Dr. Kamal Kant Kohli14 Nov 2024 8:00 PM ISTResearchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a probiotic-based therapeutic that...
NEJM: Results from targeted therapy for ulcerative colitis study Dr. Kamal Kant Kohli30 Sept 2024 2:00 AM ISTAn international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai...
